No active infections requiring systemic antibiotic treatment (oral antibiotics are acceptable at the discretion of the treating physician) Use of antibiotics to treat chronic infections within days prior to first dose Active systemic infections requiring antibiotics Active infections requiring antibiotics, physician monitoring or recurrent fevers >.?F (.?C) associated with a clinical diagnosis of active infection Active serious infections not controlled by antibiotics Patients who have an active infection requiring systemic therapy are not eligible, except for uncomplicated urinary tract infections Must have no ongoing active, uncontrolled infections (afebrile for > hours off antibiotics) Repeated infections requiring oral or i.v. antibiotics Patient with active, uncontrolled infections (patients must be afebrile for > hours off antibiotics). Active or fungal infections requiring systemic treatment within days prior to screening Patients with active systemic infections requiring intravenous antibiotics within week prior to enrollment Has an active infection requiring systemic therapy (apart from cutaneous infections). Active uncontrolled systemic infections (defined as infections causing fevers and infections requiring intravenous antibiotics when the intravenous antibiotics have been administered for less than hours); active coagulation disorders or other major uncontrolled medical illnesses of the cardiovascular, respiratory, endocrine, renal, gastrointestinal, genitourinary or immune system; history of myocardial infarction; history of ventricular tachycardia or ventricular fibrillation; active cardiac arrhythmias (active atrial fibrillation is not allowed, but resolved atrial fibrillation is allowed); active obstructive or restrictive pulmonary disease; or active autoimmune diseases such as rheumatoid arthritis No active infections requiring systemic antibiotics Active uncontrolled systemic infections (defined as infections causing fevers and infections requiring intravenous antibiotics when intravenous antibiotics have been administered for less than hours), active coagulation disorders or other major uncontrolled medical illnesses of the cardiovascular, respiratory, endocrine, renal, gastrointestinal, genitourinary or immune system, history of myocardial infarction, history of ventricular tachycardia or ventricular fibrillation, active cardiac arrhythmias (active atrial fibrillation is not allowed, resolved atrial fibrillation not requiring current treatment is allowed [anticoagulants count as current treatment]), active obstructive or restrictive pulmonary disease, active autoimmune diseases such as rheumatoid arthritis Active HBV or HCV infections requiring therapy. Active serious infections not controlled by antibiotics Active serious infections not controlled by antibiotics Histry of significant chronic or recurrent infections requiring treatment Has an active infection requiring systemic therapy or history of repeated infections Serious, active infections requiring treatment with IV antibiotics All infections must be resolved and the patient must remain afebrile for seven days without antibiotics prior to being placed on study Active systemic infections requiring intravenous antibiotics Patients with known systemic infections requiring antibiotics or chronic maintenance/suppressive therapy Patients with systemic infections requiring active therapy within hours of lymphodepletion Patients with active systemic infections requiring antibiotics or active hepatitis A, B, or C. No active infections requiring systemic therapy Active (acute or chronic) or uncontrolled severe infections requiring intravenous antibiotics Patients who have active infections requiring therapy. Patients with infections requiring intravenous (IV) antibiotic/antiviral therapy are not eligible for entry onto the study; patients on prophylactic antibiotics or antivirals are acceptable. Severe infections necessitating use of antibiotics / antivirals during the screening period Serious, active infections must be controlled; patients may be enrolled while still on antibiotics as long as clinical signs of active infection are absent Serious, active infections requiring treatment with intravenous (IV) antibiotics Active serious infections not controlled by antibiotics Patients with active infections requiring systemic treatment. Active systemic infections requiring intravenous antibiotics Active infections requiring systemic antibiotics. Active infections requiring systemic antibiotics. Patients must be free of active infections requiring antibiotics, with the exception of uncomplicated urinary tract infections (UTIs) Active uncontrolled serious infection or sepsis at study enrollment; patients receiving antibiotics for infections that are under control may be included in the study Active infections prior to receiving study treatment or systemic infection requiring chronic maintenance or suppressive therapy Active infections requiring antibiotics Patients with systemic infections requiring antibiotics or chronic maintenance/suppressive therapy Serious, active infections must be controlled; patients may be enrolled while still on antibiotics as long as clinical signs of active infection have resolved Chronic or current active infections requiring systemic antibiotics, antifungals or antiviral therapy Patients with important infections requiring antibiotics are INELIGIBLE, but patients who acquire minor infections while on the study may remain on the study Active systemic infections requiring intravenous antibiotics Patients with active systemic infections requiring antibiotics or chronic maintenance/suppressive therapy; once the infection in question has resolved and patient is off antimicrobial treatment, patients may participate Active serious infections uncontrolled by antibiotics Active infections requiring systemic therapy Subject has known or suspected HIV or other active infections requiring acute or chronic treatment with systemic antibiotics. Conditions requiring topical antibiotics are acceptable. Active serious infections not controlled by antibiotics Active acute infection (i.e. currently treated with antibiotics); patients with chronic infections such as hepatitis B or C, mycobacterium avium or similar infections will be eligible provided they meet all other eligibility criteria